|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goebel C, Louden CL, McKenna R Jr, Onugha
O, Wachtel A and Long T: Diagnosis of non-small cell lung cancer
for early stage asymptomatic patients. Cancer Genomics Proteomics.
16:229–244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du H, Sun J, Chen Z, Nie J, Tong J and Li
J: Cigarette smoke-induced failure of apoptosis resulting in
enhanced neoplastic transformation in human bronchial epithelial
cells. J Toxicol Environ Health A. 75:707–720. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang H, Ji Y, Zhang J, Su Z, Liu M, Tong
J, Ge C, Chen T and Li J: Aberrant DNA methylation in radon and/or
cigarette smoke-induced malignant transformation in BEAS-2B human
lung cell line. J Toxicol Environ Health A. 80:1321–1330. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Yu XF, Ouyang N, Zhao S, Yao H,
Guan X, Tong J, Chen T and Li JX: MicroRNA and mRNA Interaction
network regulates the malignant transformation of human bronchial
epithelial cells induced by Cigarette smoke. Front Oncol.
9:10292019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaravinos A: The regulatory role of
MicroRNAs in EMT and cancer. J Oncol. 2015:8658162015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gros J and Tabin CJ: Vertebrate limb bud
formation is initiated by localized epithelial-to-mesenchymal
transition. Science. 343:1253–1256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Correa-Costa M, Andrade-Oliveira V, Braga
TT, Castoldi A, Aguiar CF, Origassa CS, Rodas AC, Hiyane MI,
Malheiros DM, Rios FJ, et al: Activation of platelet-activating
factor receptor exacerbates renal inflammation and promotes
fibrosis. Lab Invest. 94:455–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grande MT, Sánchez-Laorden B, López-Blau
C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ,
López-Novoa JM and Nieto MA: Snail1-induced partial
epithelial-to-mesenchymal transition drives renal fibrosis in mice
and can be targeted to reverse established disease. Nat Med.
21:989–997. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dhayat SA, Mardin WA, Köhler G, Bahde R,
Vowinkel T, Wolters H, Senninger N, Haier J and Mees ST: The
microRNA-200 family - a potential diagnostic marker in
hepatocellular carcinoma? J Surg Oncol. 110:430–438. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bojmar L, Karlsson E, Ellegård S, Olsson
H, Björnsson B, Hallböök O, Larsson M, Stål O and Sandström P: The
role of microRNA-200 in progression of human colorectal and breast
cancer. PLoS One. 8:e848152013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kan CW, Hahn MA, Gard GB, Maidens J, Huh
JY, Marsh DJ and Howell VM: Elevated levels of circulating
microRNA-200 family members correlate with serous epithelial
ovarian cancer. BMC Cancer. 12:6272012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pacurari M, Addison JB, Bondalapati N, Wan
YW, Luo D, Qian Y, Castranova V, Ivanov AV and Guo NL: The
microRNA-200 family targets multiple non-small cell lung cancer
prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol.
43:548–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng B, Wang R and Chen LB: Review of
miR-200b and cancer chemosensitivity. Biomed Pharmacother.
66:397–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu K, Zhang W, Tan J, Ma J and Zhao J:
miR-200b-3p functions as an oncogene by targeting ABCA1 in lung
adenocarcinoma. Technol Cancer Res Treat. 18:15330338198925902019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldman MJ, Craft B, Hastie M, Repečka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
Visualizing and interpreting cancer genomics data via the Xena
platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vucic EA, Thu KL, Pikor LA, Enfield KS,
Yee J, English JC, MacAulay CE, Lam S, Jurisica I and Lam WL:
Smoking status impacts microRNA mediated prognosis and lung
adenocarcinoma biology. BMC Cancer. 14:7782014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Jin Y, Yuan Y, Bai C, Wu Y, Zhu H
and Lu S: Validation and target gene screening of hsa-miR-205 in
lung squamous cell carcinoma. Chin Med J (Engl). 127:272–278.
2014.PubMed/NCBI
|
|
24
|
Arima C, Kajino T, Tamada Y, Imoto S,
Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T,
et al: Lung adenocarcinoma subtypes definable by lung
development-related miRNA expression profiles in association with
clinicopathologic features. Carcinogenesis. 35:2224–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bjaanaes MM, Halvorsen AR, Solberg S,
Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M,
Pastorino U, Kure E, et al: Unique microRNA-profiles in
EGFR-mutated lung adenocarcinomas. Int J Cancer. 135:1812–1821.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC, et al: Identification
of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in
nonsmoking women. Cancer Epidemiol Biomarkers Prev. 19:2590–2597.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei TY, Juan CC, Hisa JY, Su LJ, Lee YC,
Chou HY, Chen JM, Wu YC, Chiu SC, Hsu CP, et al: Protein arginine
methyltransferase 5 is a potential oncoprotein that upregulates G1
cyclins/cyclin-dependent kinases and the phosphoinositide
3-kinase/AKT signaling cascade. Cancer Sci. 103:1640–1650. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Whiteaker JR, Halusa GN, Hoofnagle AN,
Sharma V, MacLean B, Yan P, Wrobel JA, Kennedy J, Mani DR,
Zimmerman LJ, et al Clinical proteomic tumor analysis consortium
(CPTAC), : CPTAC assay portal: A repository of targeted proteomic
assays. Nat Methods. 11:703–704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: A prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shinozaki A, Sakatani T, Ushiku T, Hino R,
Isogai M, Ishikawa S, Uozaki H, Takada K and Fukayama M:
Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Cancer Res. 70:4719–4727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He M, Liu Y, Deng X, Qi S, Sun X, Liu G,
Liu Y, Liu Y and Zhao M: Down-regulation of miR-200b-3p by low p73
contributes to the androgen-independence of prostate cancer cells.
Prostate. 73:1048–1056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Guan B, Liu J, Zhang Z, He S, Zhan
Y, Su B, Han H, Zhang X, Wang B, et al: MicroRNA-200b is
downregulated and suppresses metastasis by targeting LAMA4 in renal
cell carcinoma. EBioMedicine. 44:439–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang HF, Alshareef A, Wu C, Jiao JW,
Sorensen PH, Lai R, Xu LY and Li EM: miR-200b induces cell cycle
arrest and represses cell growth in esophageal squamous cell
carcinoma. Carcinogenesis. 37:858–869. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Xing T, Chen Y and Xiao J:
Exosome-mediated miR-200b promotes colorectal cancer proliferation
upon TGF-β1 exposure. Biomed Pharmacother. 106:1135–1143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng F, Xue M, Xiao T, Li Y, Xiao S, Jiang
B and Ren C: MiR-200b promotes the cell proliferation and
metastasis of cervical cancer by inhibiting FOXG1. Biomed
Pharmacother. 79:294–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu Y, Liu X, Zhou N, Du L, Sun Y, Zhang X
and Ge Y: MicroRNA-200b stimulates tumour growth in TGFBR2-null
colorectal cancers by negatively regulating p27/kip1. J Cell
Physiol. 229:772–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vrijens K, Bollati V and Nawrot TS:
MicroRNAs as potential signatures of environmental exposure or
effect: A systematic review. Environ Health Perspect. 123:399–411.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang C, Kam RKT, Shi W, Xia Y, Chen X, Cao
Y, Sun J, Du Y, Lu G, Chen Z, et al: The proto-oncogene
transcription factor Ets1 regulates neural crest development
through histone deacetylase 1 to mediate output of bone
morphogenetic protein signaling. J Biol Chem. 290:21925–21938.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shaikhibrahim Z and Wernert N: ETS
transcription factors and prostate cancer: The role of the family
prototype ETS-1 (Review). Int J Oncol. 40:1748–1754.
2012.PubMed/NCBI
|
|
41
|
Dittmer J: The role of the transcription
factor Ets1 in carcinoma. Semin Cancer Biol. 35:20–38. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J,
Xing R, Jin Y, Sun Z and Zheng X: MicroRNA-193b regulates
proliferation, migration and invasion in human hepatocellular
carcinoma cells. Eur J Cancer. 46:2828–2836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y
and Zheng X: MicroRNA-1 and microRNA-499 downregulate the
expression of the ets1 proto-oncogene in HepG2 cells. Oncol Rep.
28:701–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma N, Chen F, Shen SL, Chen W, Chen LZ, Su
Q, Zhang LJ, Bi J, Zeng WT, Li W, et al: MicroRNA-129-5p inhibits
hepatocellular carcinoma cell metastasis and invasion via targeting
ETS1. Biochem Biophys Res Commun. 461:618–623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chan YC, Khanna S, Roy S and Sen CK:
miR-200b targets Ets-1 and is down-regulated by hypoxia to induce
angiogenic response of endothelial cells. J Biol Chem.
286:2047–2056. 2011. View Article : Google Scholar : PubMed/NCBI
|
